Cargando…

Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is the leading cause of death from gynecological malignancies. Recent studies have focused on ovarian cancer-associated microRNAs that play strong regulatory roles in various cellular processes. While miRNAs have been shown to participate in regulation of tumorigenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajek, Arkadiusz, Gralewska, Patrycja, Marczak, Agnieszka, Rogalska, Aneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199164/ https://www.ncbi.nlm.nih.gov/pubmed/34072593 http://dx.doi.org/10.3390/cancers13112690

Ejemplares similares

Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
por: Gralewska, Patrycja, et al.
Publicado: (2020)

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
por: Gralewska, Patrycja, et al.
Publicado: (2021)

The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCA(MUT) and BRCA(WT) Ovarian Cancer Cells
por: Gralewska, Patrycja, et al.
Publicado: (2022)

PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness
por: Gralewska, Patrycja, et al.
Publicado: (2020)

Olaparib-Resistant BRCA2(MUT) Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival
por: Biegała, Łukasz, et al.
Publicado: (2023)

Novel oxazolinoanthracyclines as tumor cell growth inhibitors—Contribution of autophagy and apoptosis in solid tumor cells death
por: Rogalska, Aneta, et al.
Publicado: (2018)

Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells
por: Poczta, Anastazja, et al.
Publicado: (2022)

Two drugs are better than one. A short history of combined therapy of ovarian cancer
por: Bukowska, Barbara, et al.
Publicado: (2014)

Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches
por: Poczta, Anastazja, et al.
Publicado: (2021)

Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
por: Rogalska, Aneta, et al.
Publicado: (2018)

Effect of metformin on apoptosis induction in ovarian cancer cells
por: Rogalska, Aneta, et al.
Publicado: (2014)

MicroRNAs and ovarian function
por: Baley, Jason, et al.
Publicado: (2012)

Antileukemic activity of novel adenosine derivatives
por: Poczta, Anastazja, et al.
Publicado: (2019)

The Role of MicroRNAs in Ovarian Cancer
por: Kinose, Yasuto, et al.
Publicado: (2014)

MicroRNAs in ovarian function and disorders
por: Li, Ying, et al.
Publicado: (2015)

Stability of circulating microRNAs in serum
por: Kupec, Tomas, et al.
Publicado: (2022)

Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
por: Köberle, Verena, et al.
Publicado: (2013)

Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)

Regulation of Metastasis by microRNAs in Ovarian Cancer
por: Wang, Yongchao, et al.
Publicado: (2014)

The Role of microRNAs in the Tumorigenesis of Ovarian Cancer
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Role of microRNAs in premature ovarian insufficiency
por: Guo, Ying, et al.
Publicado: (2017)

MicroRNAs as Key Regulators of Ovarian Cancers
por: Satapathy, Sandeep, et al.
Publicado: (2019)

Chemical modification of melphalan as a key to improving treatment of haematological malignancies
por: Gajek, Arkadiusz, et al.
Publicado: (2020)

Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis
por: Marí-Alexandre, Josep, et al.
Publicado: (2019)

Regulation of MicroRNAs, and the Correlations of MicroRNAs and Their Targeted Genes by Zinc Oxide Nanoparticles in Ovarian Granulosa Cells
por: Zhao, Yong, et al.
Publicado: (2016)

The role of microRNAs in ovarian cancer initiation and progression
por: Li, Shuang-Di, et al.
Publicado: (2010)

Epigenetic Control of Autophagy by MicroRNAs in Ovarian Cancer
por: Titone, Rossella, et al.
Publicado: (2014)

MicroRNAs and Recent Insights into Pediatric Ovarian Cancers
por: Francis, Jessica C., et al.
Publicado: (2013)

Identification of microRNAs as potential markers of ovarian toxicity
por: Furlong, Hayley C., et al.
Publicado: (2018)

The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
por: Nguyen, Vu Hong Loan, et al.
Publicado: (2020)

Retraction: The role of microRNAs in the tumorigenesis of ovarian cancer
Publicado: (2020)

The Current State of MicroRNAs as Restenosis Biomarkers
por: Varela, Nelson, et al.
Publicado: (2020)

Clinical implications of microRNAs in human glioblastoma
por: Mizoguchi, Masahiro, et al.
Publicado: (2013)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
por: Chafin, Cristen B., et al.
Publicado: (2013)

MicroRNAs and clinical implications in hepatocellular carcinoma
por: Mohamed, Amal Ahmed, et al.
Publicado: (2017)

MicroRNAs: Crucial Regulators of Stress
por: Roufayel, Rabih, et al.
Publicado: (2020)

The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress
por: Włodarski, Adam, et al.
Publicado: (2020)

Mathematics of microRNAs: stabilizing gene regulatory networks
por: Ambros, Victor
Publicado: (2019)

Regulation of the unfolded protein response by microRNAs
por: Bartoszewska, Sylwia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cs4mfn76e67rl530dma9j9stik